Quantitative measurement of diamine oxidase (DAO) enzyme concentration from dried blood spot by ELISA for assessment of histamine intolerance and DAO deficiency.
This method quantifies diamine oxidase (DAO) enzyme concentration from a dried blood spot to assess histamine intolerance and DAO deficiency. DAO is the primary enzyme responsible for degrading dietary histamine in the gastrointestinal tract. Low DAO activity or concentration permits histamine to accumulate systemically, leading to delayed pseudo-allergic reactions despite negative conventional allergy testing.
Clinical indications for DAO measurement include:
Estimated prevalence of DAO deficiency is 1–3% of the general population, making histamine intolerance a modifiable condition affecting a meaningful portion of patients presenting with non-allergic allergy-like symptoms. Diagnosis enables dietary modification and consideration of DAO supplementation, both of which can dramatically improve quality of life.
Histamine is an important signalling molecule synthesised from the amino acid L-histidine by histidine decarboxylase. While much of the body's histamine is produced endogenously (particularly by mast cells and basophils), additional histamine is acquired from dietary sources including aged cheeses, processed meats, fermented foods, certain wines, and other products with high biogenic amine content.
Estimated population prevalence of DAO deficiency, making it a common but often unrecognised condition
Symptoms mimic allergic reactions but conventional allergy tests are normal, leading to years of diagnostic uncertainty
Dietary restriction of high-histamine foods and DAO supplementation can produce rapid symptom resolution
Histamine is degraded via two principal enzymatic pathways: the primary pathway is mediated by diamine oxidase (DAO), a copper-dependent enzyme expressed throughout the gastrointestinal tract, particularly in the intestinal mucosa and the liver. The secondary pathway uses histamine N-methyltransferase (HNMT), which is expressed predominantly in the central nervous system and other tissues. When DAO activity is reduced, either from genetic factors, acquired enzyme suppression, or intestinal barrier compromise, histamine accumulates and enters systemic circulation.
Causes of DAO deficiency include: genetic polymorphisms and mutations affecting DAO expression or function; medications that suppress DAO activity (NSAIDs, antihistamines, cimetidine, certain antibiotics, alcohol); and acquired deficiency from intestinal inflammation, dysbiosis, or damage to the intestinal epithelium. Patients with inflammatory bowel disease, small intestinal bacterial overgrowth (SIBO), or celiac disease frequently develop acquired DAO deficiency because the inflammatory milieu suppresses enzyme expression and/or damages the intestinal mucosa that produces DAO.
The clinical manifestations of histamine intolerance are diverse and frequently mimic IgE-mediated allergic reactions but occur with a delay of 30 minutes to several hours after histamine ingestion. Common symptoms include migraine headaches, flushing and pruritus (skin itching), gastrointestinal symptoms (abdominal cramping, diarrhoea, nausea), nasal congestion or rhinorrhoea, and fatigue. Because these symptoms are delayed and variable in their presentation, histamine intolerance is frequently misattributed to true food allergies, idiopathic urticaria, or psychological causes.
Diamine oxidase is quantified from dried blood spots using enzyme-linked immunosorbent assay (ELISA). The method measures total DAO protein concentration via sandwich ELISA using monoclonal antibodies specific to human DAO. This approach quantifies the absolute amount of enzyme present, distinct from enzyme activity assays which measure catalytic function.
ELISA measurement of DAO concentration from DBS is advantageous because: it requires minimal sample volume from a convenient heel prick; DBS samples are stable at ambient temperature; and the semi-quantitative approach provides clear discrimination between normal and deficient DAO levels. Results are typically expressed in units per millilitre (U/mL) or as categorical classifications (normal, low-normal, deficient) based on reference ranges established in the healthy population.
Dried blood spot collection is ideal for DAO measurement. The sample is stable at room temperature and does not require special handling or rapid processing. DBS collection is suitable for all ages and enables convenient home or point-of-care testing, facilitating broad access to histamine intolerance assessment in clinical and wellness settings.
Whether you need testing services, method transfer, or white-label kit development — we'd love to hear from you.